Arterial Hypertension and Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis

Background: Off-target effects in chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKIs) are associated with cardiovascular toxicity. Hypertension represents an important cardiovascular complication and, if not appropriately managed, can contribute to developing throm...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulas, Olga, Caocci, Giovanni, Mola, Brunella, La Nasa, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493251/
https://www.ncbi.nlm.nih.gov/pubmed/34630076
http://dx.doi.org/10.3389/fphar.2021.674748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493251/
https://www.ncbi.nlm.nih.gov/pubmed/34630076
http://dx.doi.org/10.3389/fphar.2021.674748

Ejemplares similares